OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

MacroGenics/  US5560991094  /

IEX
2024-06-06  9:59:58 PM Chg. -0.24 Volume Bid- Ask- High Low
4.68USD -4.79% 16,171
Turnover: 76,470.73		 -Bid Size: - -Ask Size: - 4.94 4.66
GlobeNewswire 06-05 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc...
GlobeNewswire 05-29 MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study – Hagens Berman
GlobeNewswire 05-28 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc...
GlobeNewswire 05-20 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc...
GlobeNewswire 05-16 MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study – Hagens Berman
GlobeNewswire 05-15 MACROGENICS ALERT: Bragar Eagel & Squire, P.C. is Investigating MacroGenics, Inc. on Behalf of Macro...
GlobeNewswire 05-14 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire 05-13 MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study – Hagens Berman
GlobeNewswire 05-13 MacroGenics to Participate in Upcoming Investor Conferences
GlobeNewswire 05-11 MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study – Hagens Berman
GlobeNewswire 05-10 INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, I...
GlobeNewswire 05-09 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire 05-03 MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
GlobeNewswire 04-24 Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board ...
GlobeNewswire 04-03 MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosur...
GlobeNewswire 03-07 MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
GlobeNewswire 03-01 MacroGenics to Participate in Upcoming Investor Conferences
GlobeNewswire 02-27 MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
GlobeNewswire 02-02 MacroGenics to Participate in Upcoming Investor Conference
GlobeNewswire 01-08 MacroGenics to Participate in Upcoming Investor Conference
GlobeNewswire 2023-11-29 Dianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Ch...
GlobeNewswire 2023-11-06 MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial Results
GlobeNewswire 2023-11-02 MacroGenics to Participate in Upcoming Investor Conferences
GlobeNewswire 2023-10-31 MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call
GlobeNewswire 2023-09-05 MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispe...